Abstract
Depression is among the most common psychiatric disorders encountered throughout the transplant process. End-stage organ failure can create situations of extreme psychological stress and social impairment that has impacts on employment, relationships, and day-to-day living. Detection of depression in the transplant setting can be difficult because of the commonly associated neurovegetative symptoms that accompany organ failure. On top of the psychological challenges associated with end-stage organ disease, the acute physical decline, social stressors, and rigorous evaluation process associated with the transplant can potentially confound the diagnosis of depression. A thorough psychiatric evaluation by an experienced transplant mental health practitioner remains the gold standard for diagnosing and deciding upon the treatment of depressive disorders. Treatment of depression is imperative in the transplant setting to provide the best outcomes postoperatively. Untreated depression in the transplant setting has been correlated with increased risk of nonadherence, length of stay, infection rates, postoperative healing, rejection, and graft loss. But due in part to ongoing bias against patients with psychiatric disorders, investment in mental health resources and participation in mental health treatment can be limited within the transplant setting.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baykan H, Yargic I. Depression, anxiety disorders, quality of life and stress coping strategies in Hemodialysis and continuous ambulatory peritoneal dialysis patients. Bull Clin Psychopharmacol. 2012;22
Corbett C, Armstrong MJ, Parker R, Webb K, Neuberger JM. Mental health disorders and solid-organ transplant recipients. Transplantation. 2013;96(7):593–600.
Dew MA, Kormos RL, DiMartini AF, Switzer GE, Schulberg HC, Roth LH, et al. Prevalence and risk of depression and anxiety-related disorders during the first three years after heart transplantation. Psychosomatics. 2001;42(4):300–13.
Milaniak I, Wilczek-Rużyczka E, Wierzbicki K, Piatek J, Kędziora A, Przybyłowski P. The effect of clinical variables on distress and depressive symptoms among heart transplant recipients. Heart Lung. 2018;47(1):68–72.
Newhouse A, Jiang W. Heart failure and depression. Heart Fail Clin. 2014;10(2):295–304.
Annema C, Roodbol PF, Van den Heuvel ER, Metselaar HJ, Van Hoek B, Porte RJ, et al. Trajectories of anxiety and depression in liver transplant candidates during the waiting-list period. Br J Health Psychol. 2017;22(3):481–501.
Dew MA, DiMartini AF, DeVito Dabbs AJ, Fox KR, Myaskovsky L, Posluszny DM, et al. Onset and risk factors for anxiety and depression during the first 2 years after lung transplantation. Gen Hosp Psychiatry. 2012;34(2):127–38.
Srifuengfung M, Noppakun K, Srisurapanont M. Depression in kidney transplant recipients: prevalence, risk factors, and association with functional disabilities. J Nerv Ment Dis. 2017;205(10):788–92.
Dew MA, Rosenberger EM, Myaskovsky L, DiMartini AF, DeVito Dabbs AJ, Posluszny DM, et al. Depression and anxiety as risk factors for morbidity and mortality after organ transplantation: a systematic review and meta-analysis. Transplantation. 2015;100(5):988–1003.
Rogal SS, Dew MA, Fontes P, DiMartini AF. Early treatment of depressive symptoms and long-term survival after liver transplantation. Am J Transplant. 2013;13(4):928–35.
Dew MA, Kormos RL, Roth LH, Murali S, DiMartini A, Griffith BP. Early post-transplant medical compliance and mental health predict physical morbidity and mortality one to three years after heart transplantation. J Heart Lung Transplant. 1999;18(6):549–62.
Dew MA, DiMartini AF, Dobbels F, Grady KL, Jowsey-Gregoire SG, Kaan A, et al. The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. Psychosomatics. 2018;59(5):415–40.
van der Donk LJ, Bickel EA, Krijnen WP, Tovote KA, Sanderman R, Schroevers MJ, et al. The value of distinct depressive symptoms (PHQ-9) to differentiate depression severity in cancer survivors: an item response approach. Psychooncology. 2019;28(11):2240–3.
Orive M, Padierna JA, Quintana JM, Las-Hayas C, Vrotsou K, Aguirre U. Detecting depression in medically ill patients: comparative accuracy of four screening questionnaires and physicians' diagnoses in Spanish population. J Psychosom Res. 2010;69(4):399–406.
Faeder S, Moschenross D, Rosenberger E, Dew MA, DiMartini A. Psychiatric aspects of organ transplantation and donation. Curr Opin Psychiatry. 2015;28(5):357–64.
Cukor D, Coplan J, Brown C, Friedman S, Newville H, Safier M, et al. Anxiety disorders in adults treated by hemodialysis: a single-center study. Am J Kidney Dis. 2008;52(1):128–36.
Yoong RK, Mooppil N, Khoo EY, Newman SP, Lee VY, Kang AW, et al. Prevalence and determinants of anxiety and depression in end stage renal disease (ESRD). A comparison between ESRD patients with and without coexisting diabetes mellitus. J Psychosom Res. 2017;94:68–72.
Gerogianni G, Lianos E, Kouzoupis A, Polikandrioti M, Grapsa E. The role of socio-demographic factors in depression and anxiety of patients on hemodialysis: an observational cross-sectional study. Int Urol Nephrol. 2018;50(1):143–54.
Mullish BH, Kabir MS, Thursz MR, Dhar A. Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation. Aliment Pharmacol Ther. 2014;40(8):880–92.
de Figueiredo JM. Depression and demoralization: phenomenologic differences and research perspectives. Compr Psychiatry. 1993;34(5):308–11.
de Figueiredo JM. Demoralization and psychotherapy: a tribute to Jerome D. frank, MD, PhD (1909–2005). Psychother Psychosom. 2007;76(3):129–33.
Riemer TG, Villagomez Fuentes LE, Algharably EAE, Schäfer MS, Mangelsen E, Fürtig MA, et al. Do β-blockers cause depression?: systematic review and meta-analysis of psychiatric adverse events during β-blocker therapy. Hypertension. 2021;77(5):1539–48.
Conway A, Schadewaldt V, Clark R, Ski C, Thompson DR, Doering L. The psychological experiences of adult heart transplant recipients: a systematic review and meta-summary of qualitative findings. Heart Lung. 2013;42(6):449–55.
Nowicka-Sauer K, Jarmoszewicz K, Pietrzykowska M, Batkiewicz S. The paradox of waiting for heart transplant: between control and fate. Exp Clin Transplant. 2017;15(6):696–9.
Milaniak I, Wilczek-Ruzyczka E, Wierzbicki K, Sadowski J, Kapelak B, Przybylowski P. Role of personal resources in depression and stress in heart transplant recipients. Transplant Proc. 2016;48(5):1761–6.
Clark S, Weale A. Social values in health priority setting: a conceptual framework. J Health Organ Manag. 2012;26(3):293–316.
Forster J, Bartholome WG, Delcore R. Should a patient who attempted suicide receive a liver transplant? J Clin Ethics. 1996;7(3):257–67.
Aulisio MP, Arnold RM. Exclusionary criteria and suicidal behavior: comment on “should a patient who attempted suicide receive a liver transplant”? J Clin Ethics. 1996;7(3):277–83.
Crone CC, Gabriel GM. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Clin Pharmacokinet. 2004;43(6):361–94.
Gamboa MC, Ferrando SJ. Psychopharmacology in transplant patients. In: Sher Y, Maldonado JR, editors. Psychosocial Care of end-stage organ disease and transplant patients. Springer; 2019. p. 453–70.
Jea MQ. APA CLINICAL PRACTICE GUIDELINE for the treatment of depression across three age cohorts. American Psychological Association; 2019.
Jadoulle V, Hoyois P, Jadoul M. Anxiety and depression in chronic hemodialysis: some somatopsychic determinants. Clin Nephrol. 2005;63(2):113–8.
Niazi SK, Spaulding A, Vargas E, Schneekloth T, Crook J, Rummans T, et al. Mental health and chemical dependency services at US transplant centers. Am J Transplant. 2020;20(4):1152–61.
O'Donnell ML, Agathos JA, Metcalf O, Gibson K, Lau W. Adjustment disorder: current developments and future directions. Int J Environ Res Public Health. 2019;16(14)
Lopes AA, Lantz B, Morgenstern H, Wang M, Bieber BA, Gillespie BW, et al. Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS. Clin J Am Soc Nephrol. 2014;9(10):1702–12.
Delibasic M, Mohamedali B, Dobrilovic N, Raman J. Pre-transplant depression as a predictor of adherence and morbidities after orthotopic heart transplantation. J Cardiothorac Surg. 2017;12(1):62.
Rogal SS, Mankaney G, Udawatta V, Chinman M, Good CB, Zickmund S, et al. Pre-transplant depression is associated with length of hospitalization, discharge disposition, and survival after liver transplantation. PLoS One. 2016;11(11):e0165517.
Smith PJ, Snyder LD, Palmer SM, Hoffman BM, Stonerock GL, Ingle KK, et al. Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study. Transpl Int. 2018;31(5):495–502.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Soeprono, T., Huijon, R.M., Lunbeck, S. (2022). Mood Disorders in Transplantation: Depressive Disorders. In: Zimbrean, P.C., Sher, Y., Crone, C., DiMartini, A.F. (eds) Transplant Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-031-15052-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-031-15052-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-15051-7
Online ISBN: 978-3-031-15052-4
eBook Packages: MedicineMedicine (R0)